Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Pérez-Elías
Clinical, Virological and Biochemical Evidence Supporting the Association of HIV-1 Reverse Transcriptase Polymorphism R284K and Thymidine Analogue Resistance Mutations M41L, L210W and T215Y in Patients Failing Tenofovir/Emtricitabine Therapy
Retrovirology
Virology
Infectious Diseases
Related publications
N348I in HIV-1 Reverse Transcriptase Decreases Susceptibility to Tenofovir and Etravirine in Combination With Other Resistance Mutations
AIDS
Infectious Diseases
Allergy
Immunology
Abacavir–Lamivudine Versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy
New England Journal of Medicine
Medicine
Selection of Nonnucleoside Reverse Transcriptase Inhibitor-Associated Mutations in HIV-1 Subtype C: Evidence of Etravirine Cross-Resistance
AIDS
Infectious Diseases
Allergy
Immunology
Anti-Hiv Drugs and Resistance: Inhibitors of HIV-1 Reverse Transcriptase and Protease
Drug Resistance Mutations in HIV Type 1 Isolates From Patients Failing Antiretroviral Therapy in Morocco
AIDS Research and Human Retroviruses
Virology
Infectious Diseases
Immunology
Resistance Analysis of Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment-Naïve Patients Through 48 Weeks
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Mutations in the Connection Domain of HIV-1 Reverse Transcriptase Increase 3'-Azido-3'-Deoxythymidine Resistance
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Primer ID Informs Next-Generation Sequencing Platforms and Reveals Preexisting Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Coding Domain
AIDS Research and Human Retroviruses
Virology
Infectious Diseases
Immunology
Reduced Immune Activation During Tenofovir–Emtricitabine Therapy in HIV-Negative Individuals
Journal of Acquired Immune Deficiency Syndromes
Infectious Diseases
Pharmacology
